Non-fullerene acceptor compound containing benzoselenadiazole and organic optoelectronic device including the same

US12139465B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12139465-B2
Application numberUS-202017105673-A
CountryUS
Kind codeB2
Filing dateNov 27, 2020
Priority dateJan 17, 2020
Publication dateNov 12, 2024
Grant dateNov 12, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a non-fullerene acceptor compound containing benzoselenadiazole, and organic optoelectronic devices comprising the same.

First claim

Opening claim text (preview).

What is claimed is: 1. A non-fullerene acceptor compound containing benzoselenadiazole having the following formula: wherein Ar 1 is a five-membered heterocyclic ring; Ar 2 is a monocyclic or polycyclic, C5, C6, C8, C9, or C10 heteroaromatic derivative; π is a monocyclic or polycyclic, C5, C6, C7, C8 or C9 heteroaromatic derivative, wherein m=0-5; and EG is a monocyclic or polycyclic derivative containing a ketone group and electron-withdrawing group. 2. The non-fullerene acceptor compound containing benzoselenadiazole according to claim 1 , wherein Ar 1 is selected from the group consisting of which the substituent R 1 of Ar 1 is selected from the group consisting of C1-C30 linear alkyl, C1-C30 branched alkyl, C1-C30 silyl, C1-C30 ester, C1-C30 alkoxy, C1-C30 alkylthio, C1-C30 haloalkyl, C1-C30 alkyl substituted with alkene groups or alkyne groups, C1-C30 cyanoalkyl, C1-C30 nitroalkyl, C1-C30 hydroxyalkyl, C1-C30 keto-alkyl, and halogen. 3. The non-fullerene acceptor compound containing benzoselenadiazole according to claim 1 , wherein Ar 2 is selected from the group consisting of which the substituent R 2 of Ar 2 is selected from the group consisting of C1-C30 linear alkyl, C1-C30 branched alkyl, C1-C30 silyl, C1-C30 ester, C1-C30 alkoxy, C1-C30 alkylthio, C1-C30 haloalkyl, C1-C30 alkyl substituted with alkene groups or alkyne groups, C1-C30 cyanoalkyl, C1-C30 nitroalkyl, C1-C30 hydroxyalkyl, C1-C30 keto-alkyl, halogen, benzene ring containing R 1 , five-membered heterocycle containing R 1 , and six-membered heterocycle containing R 1 , R 1 is selected from the group consisting of C1-C30 linear alkyl, C1-C30 branched alkyl, C1-C30 silyl, C1-C30 ester, C1-C30 alkoxy, C1-C30 alkylthio, C1-C30 haloalkyl, C1-C30 alkyl substituted with alkene groups or alkyne groups, C1-C30 cyanoalkyl, C1-C30 nitroalkyl, C1-C30 hydroxyalkyl, C1-C30 keto-alkyl, and halogen. 4. The non-fullerene acceptor compound containing benzoselenadiazole according to claim 1 , wherein the π is selected from the group consisting of which the substituent R 3 of π is selected from the consisting of C1-C30 linear alkyl, C1-C30 branched alkyl, C1-C30 silyl, C1-C30 ester, C1-C30 alkoxy, C1-C30 alkylthio, C1-C30 haloalkyl, C1-C30 alkyl substituted with alkene groups or alkyne groups, C1-C30 cyanoalkyl, C1-C30 nitroalkyl, C1-C30 hydroxyalkyl, C1-C30 keto-alkyl, and halogen. 5. The non-fullerene acceptor compound containing benzoselenadiazole according to claim 1 , wherein the EG is selected from the group consisting of which the substituent R 4 of EG is selected from the group consisting of hydrogen atom, halogen, C1-C20 alkyl, C1-C20 alkoxy, C1-C20 carbonyl, C1-C20 ester, and C1-C20 cyano. 6. An organic optoelectronic device comprising: a substrate; a bottom electrode disposed on the substrate; a top electrode arranged opposite to the bottom electrode; and an intermediate layer which is mounted between the bottom electrode and the top electrode and including a first carrier transport layer comprising molybdenum trioxide (MoO 3 ), a second carrier transport layer comprising zinc oxide (ZnO), and an active layer which is arranged between the first carrier transport layer and the second carrier transport layer and including a polymer donor and a non-fullerene acceptor compound containing benzoselenadiazole having the following structural formula wherein Ar 1 is a five-membered heterocyclic ring; Ar 2 is a monocyclic or polycyclic, C5, C6, C8, C9, or C10 heteroaromatic derivative; π is a monocyclic or polycyclic, C5, C6, C7, C8 or C9 heteroaromatic derivative, wherein m=0-5; and EG is a monocyclic or polycyclic derivative containing a ketone group and electron-withdrawing group. 7. The organic optoelectronic device according to claim 6 , wherein the active layer is arranged over the first carrier transport layer and the second carrier transport layer is disposed over the active layer. 8. The organic optoelectronic device according to claim 6 , wherein the active layer is arranged over the second carrier transport layer and the first carrier transport layer is disposed over the active layer. 9. The organic optoelectronic device according to claim 6 , wherein the Ar 1 is selected from the group consisting of which the substituent R 1 of Ar 1 is selected from the group consisting of C1-C30 linear alkyl, C1-C30 branched alkyl, C1-C30 silyl, C1-C30 ester, C1-C30 alkoxy, C1-C30 alkylthio, C1-C30 haloalkyl, C1-C30 alkyl substituted with alkene groups or alkyne groups, C1-C30 cyanoalkyl, C1-C30 nitroalkyl, C1-C30 hydroxyalkyl, C1-C30 keto-alkyl, and halogen. 10. The organic optoelectronic device according to claim 6 , wherein the Ar 2 is selected from the group consisting of: which the substituent R 2 of Ar 2 is selected from the group consisting of C1-C30 linear alkyl, C1-C30 branched alkyl, C1-C30 silyl, C1-C30 ester, C1-C30 alkoxy, C1-C30 alkylthio, C1-C30 haloalkyl, C1-C30 alkyl substituted with alkene groups or alkyne groups, C1-C30 cyanoalkyl, C1-C30 nitroalkyl, C1-C30 hydroxyalkyl, C1-C30 keto-alkyl, halogen, benzene ring containing R 1 , five-membered heterocycle containing R 1 , and six-membered heterocycle containing R 1 , R 1 is selected from the group consisting of C1-C30 linear alkyl, C1-C30 branched alkyl, C1-C30 silyl, C1-C30 ester, C1-C30 alkoxy, C1-C30 alkylthio, C1-C30 haloalkyl, C1-C30 alkyl substituted with alkene groups or alkyne groups, C1-C30 cyanoalkyl, C1-C30 nitroalkyl, C1-C30 hydroxyalkyl, C1-C30 keto-alkyl, and halogen. 11. The organic optoelectronic device according to claim 6 , wherein the π is selected from the group consisting of which the substituent R 3 of the π is selected from the consisting of C1-C30 linear alkyl, C1-C30 branched alkyl, C1-C30 silyl, C1-C30 ester, C1-C30 alkoxy, C1-C30 alkylthio, C1-C30 haloalkyl, C1-C30 alkyl substituted with alkene groups or alkyne groups, C1-C30 cyanoalkyl, C1-C30 nitroalkyl, C1-C30 hydroxyalkyl, C1-C30 keto-alkyl, and halogen. 12. The organic optoelectronic device according to claim 6 , wherein the EG is selected from the group consis

Assignees

Inventors

Classifications

  • Photovoltaic [PV] devices · CPC title

  • comprising a multilayered structure · CPC title

  • Polyethylene dioxythiophene [PEDOT]; Derivatives thereof · CPC title

  • Copolymers · CPC title

  • Heteroaromatic compounds comprising sulfur or selene, e.g. polythiophene · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12139465B2 cover?
The present invention relates to a non-fullerene acceptor compound containing benzoselenadiazole, and organic optoelectronic devices comprising the same.
Who is the assignee on this patent?
Raynergy Tek Inc
What technology area does this patent fall under?
Primary CPC classification C07D293/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).